Status:
COMPLETED
Maternal 25-hydroxy Vitamin D Level and Adverse Outcomes in Near Term and Full Term Neonates
Lead Sponsor:
Cairo University
Conditions:
Neonatal Outcome
Eligibility:
FEMALE
20-40 years
Brief Summary
Eighty-eight pregnant women and their newborns were enrolled in a cross-sectional study. Maternal serum 25-OHD was measured by ELISA
Detailed Description
Eighty-eight pregnant women and their newborns were enrolled in a cross-sectional study. Maternal serum 25-OHD was measured by ELISA.Maternal 25 (OH) vitamin D measurement: Blood samples for determina...
Eligibility Criteria
Inclusion
- Healthy women Term pregnancy
Exclusion
- any chronic illness as chronic hypertension or pregestational diabetes pregnancy-related illnesses as preeclampsia, gestational diabetes multiple pregnancy
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 24 2018
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03451864
Start Date
September 1 2016
End Date
February 24 2018
Last Update
March 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy medical school
Cairo, Egypt, 12111